Fund Holdings — Iron Triangle Partners LP

Total Portfolio Value:
$711.18M
Total Bought:
$373.49M
Total Sold:
$626.72M
Net Transaction:
-$253.23M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Medpace Holdings, Inc.(MEDP)0192,842+192,842$0$64.37M9.05%+$64.37M
Elanco Animal Health Incorporated(ELAN)3,228,4394,263,343+1,034,904$46.59M$62.63M8.81%+$16.04M
Illumina, Inc.(ILMN)0440,000+440,000$0$57.38M8.07%+$57.38M
Tenet Healthcare Corporation(THC)0308,940+308,940$0$51.35M7.22%+$51.35M
Acadia Healthcare Company, Inc.(ACHC)839,075802,151-36,924$56.67M$50.86M7.15%-$5.81M
Envista Holdings Corporation(NVST)02,189,369+2,189,369$0$43.26M6.08%+$43.26M
Intuitive Surgical, Inc.(ISRG)120,98672,001-48,985$53.82M$35.37M4.97%-$18.45M
Teva Pharmaceutical Industries LimitedADS(TEVA)3,300,1851,943,790-1,356,395$53.63M$35.03M4.93%-$18.60M
Oscar Health, Inc.CL A(OSCR)1,832,2561,611,909-220,347$28.99M$34.19M4.81%+$5.20M
Danaher Corporation(DHR)187,011110,000-77,011$46.72M$30.58M4.30%-$16.14M
Glaukos Corporation(GKOS)508,156217,674-290,482$60.14M$28.36M3.99%-$31.78M
Endeavour Silver Corp.(EXK)0399,871+399,871$0$27.24M3.83%+$27.24M
Insulet Corporation(PODD)264,041110,000-154,041$53.28M$25.60M3.60%-$27.68M
Merit Medical Systems, Inc.(MMSI)0253,000+253,000$0$25.00M3.52%+$25.00M
Twist Bioscience Corporation(TWST)526,455510,000-16,455$25.94M$23.04M3.24%-$2.90M
Axsome Therapeutics, Inc.(AXSM)0252,266+252,266$0$22.67M3.19%+$22.67M
Geron Corporation(GERN)03,351,000+3,351,000$0$15.21M2.14%+$15.21M
SanofiADR(SNY)0261,741+261,741$0$15.08M2.12%+$15.08M
Brookdale Senior Living Inc.(BKD)5,801,9412,197,578-3,604,363$39.63M$14.92M2.10%-$24.71M
Insmed Incorporated(INSM)413,196180,000-233,196$27.68M$13.14M1.85%-$14.54M
Acadia Pharmaceuticals Inc0750,000+750,000$0$11.54M1.62%+$11.54M
Myriad Genetics, Inc.(MYGN)0401,859+401,859$0$11.01M1.55%+$11.01M
Indivior Plc0845,470+845,470$0$8.24M1.16%+$8.24M
Bicara Therapeutics Inc0200,000+200,000$0$5.09M0.72%+$5.09M
908 Devices Inc.(MASS)728,8650-728,865$3.75M$0—-$3.75M
AbbVie Inc.(ABBV)284,6570-284,657$48.82M$0—-$48.82M
agilon health, inc.(AGL)2,519,4160-2,519,416$16.48M$0—-$16.48M
Alumis Inc125,0000-125,000$1.66M$0—-$1.66M
argenx SEADR(ARGX)61,7040-61,704$26.54M$0—-$26.54M
BioMarin Pharmaceutical Inc.(BMRN)555,1400-555,140$45.70M$0—-$45.70M
DexCom, Inc.(DXCM)582,1990-582,199$66.01M$0—-$66.01M
Edwards Lifesciences Corp727,1800-727,180$67.17M$0—-$67.17M
Inspire Medical Systems, Inc.(INSP)281,9920-281,992$37.74M$0—-$37.74M
McKesson Corporation(MCK)92,1250-92,125$53.80M$0—-$53.80M
Neurocrine Biosciences, Inc.(NBIX)200,0000-200,000$27.53M$0—-$27.53M
Schrödinger, Inc.(SDGR)1,133,1020-1,133,102$21.91M$0—-$21.91M
West Pharmaceutical Services, Inc.(WST)132,9080-132,908$43.78M$0—-$43.78M
Page 1 of 1
Iron Triangle Partners LP — 13F Holdings — Q3 2024 | TickerTrail